<DOC>
	<DOCNO>NCT00666536</DOCNO>
	<brief_summary>The purpose trial compare blood pressure lower efficacy moderate Valsartan + Amlodipine treatment regimen ( 160 / 5 mg ) aggressive regimen ( 320 / 10 mg ) patient uncontrolled ARB monotherapy , Valsartan</brief_summary>
	<brief_title>The Effects Moderate v . Aggressive Treatment With Valsartan + Amlodipine Patients With Hypertension Uncontrolled Angiotensin-Receptor Blocker ( Herein , ARB ) Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>Male female outpatient 18 Years age old Mean Sitting Systolic Blood Pressure ( top number ) great equal 150 mmHg low 200 mmHg AngiotensinReceptor Blocker monotherapy minimum period 28 day prior randomization Mean Sitting Systolic Blood Pressure ( top number ) great equal 200 mmHg and/or Mean Sitting Diastolic Blood Pressure great equal 120 mmHg Transient ischemic attack ( ministroke ) , myocardial infarction ( heart attack ) , type revascularization procedure last 6 month Treatment valsartan combination antihypertensive treatment 28 day prior screen ( Visit 1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>adult</keyword>
	<keyword>Valsartan + Amlodipine</keyword>
	<keyword>Angiotensin Receptor Blockers</keyword>
</DOC>